[ccpw id="5"]

Home.forex news report“On Paper, This One’s a Standout”

“On Paper, This One’s a Standout”

-


Circle Internet Group (NYSE:CRCL) is one of the stocks Jim Cramer talked about. Cramer highlighted the stock’s gain to nearly $300 post-IPO. The Mad Money host commented:

“Alright, let’s start with Circle Internet Group. Let me explain how this works. This is a stablecoin issuer. On paper, this one’s a standout. It’s up 160% from where it came public. But Circle’s IPO priced at $31, and then it opened at $69, then zoomed all the way to $299 in less than 3 weeks after it came public. Ever since, the stock’s practically been in freefall, now it’s back to $80 and change. So, sure, yes, it’s a big win if you got in on the IPO. Very few people did, but unless you did, well, you know what? You’re down big in this, big… Circle Internet came public, more than tripling in its first few days, I said you had to cool your jets. Good call. Of course, Circle proceeded to surge from $115 at the time to just under $300 over the next couple weeks… But if you sold when I went negative, you still would have avoided some massive losses down the road. Maybe that’s the key.”

Stock market data. Photo by Jakub Zerdzicki on Pexels

Circle Internet Group (NYSE:CRCL) operates a stablecoin-based financial platform that helps organizations move money and build applications using digital assets.

While we acknowledge the potential of CRCL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS

Truist Raises PT on Amneal Pharmaceuticals (AMRX) to $15 From $14

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is one of the best performing pharma stocks in 2025. On January 7, Truist raised the price...

Amarin Corporation (AMRN) Announces Select Unaudited Financial Highlights

Amarin Corporation plc (NASDAQ:AMRN) is one of the best performing pharma stocks in 2025. Amarin Corporation plc (NASDAQ:AMRN) announced select unaudited...

Jefferies Reaffirms a Buy Rating on GSK plc (GSK) – Here’s Why

GSK plc (NYSE:GSK) is one of the best performing pharma stocks in 2025. Jefferies reaffirmed a Buy rating on GSK plc...

Eli Lilly and Company (LLY) to Acquire Ventyx Biosciences

Eli Lilly and Company (NYSE:LLY) is one of the best performing pharma stocks in 2025. Eli Lilly and Company (NYSE:LLY) announced...

Follow us

0FansLike
0FollowersFollow
0SubscribersSubscribe

Most Popular

spot_img